Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PSI CRO has built a reputation for on-time delivery of global pivotal registrational studies with high repeat/referral rates (>90%). The company has received multiple industry awards recognizing its expertise and reliability. It does not develop its own therapeutics but enables sponsors to achieve timely patient enrollment and successful trial execution across more than sixty countries. Recent recognitions include the Fierce Biotech Award finalist status in Excellence in Clinical Trial Management for 2025 and seven consecutive years of leadership awards from Clinical Leader/Life Science Connect based on sponsor feedback.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PSI CRO.